Protara Therapeutics(TARA)
NEW YORK, NYBiotechnology
Focus: Protara Therapeutics is a public-stage biotechnology company headquartered in New York focused on cell therapy and gene therapy. The company operates at pre-revenue with a focused pipeline in rare and orphan indications.
Profile data last refreshed 12h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
3
Should You Work at Protara Therapeutics?
AI assessmentBest fit for cell therapy specialists and rare-disease clinical professionals willing to tolerate early-stage execution risk in exchange for meaningful science and reasonable cash runway.
Why Work Here
- Company holds $163M cash (FY 2025), recently raised capital, providing 18-24 month runway for pipeline advancement without immediate restructuring pressure
Data completeness
5/9 — Partial
Company HealthSolid
Pipeline
Early-stage
6 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition
Intestinal Failure-associated Liver DiseaseClinical Trials (1)
NCT05011370Prevalence of Liver Disease in Patients Dependent on Parenteral Nutrition
N/AHelp build intelligence for Protara Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.